Amicus Therapeutics (NasdaqGM:FOLD) Q3 2025 Earnings Call November 04, 2025 08:30 AM ET Company ParticipantsSimon Harford - CFOJeff Castelli - Chief Development OfficerBradley Campbell - President, CEO, and DirectorSébastien Martel - Chief Business OfficerAndrew Faughnan - VP of Investor RelationsConference Call ParticipantsAnupam Rama - Managing Director and Senior Equity Research AnalystRick Miller - AnalystSalveen Richter - AnalystJoe Schwartz - Senior Research AnalystMaxwell Skor - Biotechnology Analyst ...